Imeka

Imeka is currently the only company that combines diffusion imaging and AI to map white matter integrity and gain insights into neuroinflammation, demyelination, and axonal loss.Therefore, through our non-invasive technology, we minimize the risks for pharmaceutical and biotechnology clients in developing treatments for neurodegenerative diseases.